Scientific Publications on Global Typhoid Fever

Updated April 10, 2023

These scientific publications are authored or co-authored by CDC scientists and/or funded by CDC’s Global Immunization Division, Center for Global Health.

2023

Typhoid fever surveillance, incidence estimates, and progress toward typhoid conjugate vaccine introduction – Worldwide, 2018–2022.
Hancuh M, Walldorf J, Minta AA, et al. MMWR Morb Mortal Wkly Rep. 2023;72(7);171–176. doi 10.15585/mmwr.mm7207a2.

Programmatic effectiveness of a pediatric typhoid conjugate vaccine campaign in Navi Mumbai, India.
Hoffman SA, LeBoa C, Date K, et al. Clinical Infectious Diseases. 2023;ciad132.

2022

Estimating typhoid incidence from community-based serosurveys: A multicohort study.
Aiemjoy K, Seidman J, Saha S, et al. Lancet Microbe. 2022;S2666-5247(22)00114-8. doi: 10.1016/S2666-5247(22)00114-8.

Incidence of typhoid and paratyphoid fever in Bangladesh, Nepal, and Pakistan: Results of the Surveillance for Enteric Fever in Asia Project.
Garrett D, Longley A, Ajemoy K, et al. Lancet Glob Health. 2022;10(7):e978-e988. doi: 10.1016/S2214-109X(22)00119-X.

Implementation of an outbreak response vaccination campaign with typhoid conjugate vaccine - Harare, Zimbabwe, 2019.
Poncin M, Marembo J, Chitando P, et al. Vaccine. 2022;12:100201. doi: 10.1016/j.jvacx.2022.100201.

Enhanced surveillance for adverse events following immunization during the 2019 typhoid conjugate vaccine campaign in Harare, Zimbabwe.
Shaum A, Mijuru H, Takamiya M, et al. Vaccine. 2022;40(26):3573-3580. doi: 10.1016/j.vaccine.2022.04.098.

2020

Diagnostic value of clinical features to distinguish enteric fever from other febrile illnesses in Bangladesh, Nepal, and Pakistan.
Aiemjoy K, Tamrakar D, Saha S, et al. Clin Infect Dis. 2020;71(Suppl 3):S257-S265. doi: 10.1093/cid/ciaa1297.

Healthcare utilization patterns for acute febrile illness in Bangladesh, Nepal, and Pakistan: Results from the Surveillance for Enteric Fever in Asia Project.
Andrews JR, Vaidya K, Saha S, et al. Clin Infect Dis. 2020;71(Suppl 3):S248-S256. doi: 10.1093/cid/ciaa1321.

The Surveillance for Enteric Fever in Asia Project (SEAP), Severe Typhoid Fever Surveillance in Africa (SETA), Surveillance of Enteric Fever in India (SEFI), and Strategic Typhoid Alliance Across Africa and Asia (STRATAA) population-based enteric fever studies: A review of methodological similarities and differences.
Carey ME, MacWright WR, Im J, et al. Clin Infect Dis. 2020;71(Suppl 2):S102-S110. doi: 10.1093/cid/ciaa367.

Decision making and implementation of the first public sector introduction of typhoid conjugate vaccine — Navi Mumbai, India, 2018.
Date K, Shimpi R, Lucy S, et al. Clin Infect Dis. 2020;71(Suppl 2):S172-S178. doi: 10.1093/cid/ciaa597.

Utilization of blood culture in South Asia for the diagnosis and treatment of febrile illness.
Hemlock C, Luby SP, Saha S, et al. Clin Infect Dis. 2020;71(Suppl 3):S266-S275. doi: 10.1093/cid/ciaa1322.

Illness severity and outcomes among enteric fever cases from Bangladesh, Nepal, and Pakistan: Data from the Surveillance for Enteric Fever in Asia Project, 2016-2019.
Longley AT, Hemlock C, Date K, et al. Clin Infect Dis. 2020;71(Suppl 3):S222-S231. doi: 10.1093/cid/ciaa1320.

Typhoid and paratyphoid cost of illness in Nepal: Patient and health facility costs from the Surveillance for Enteric Fever in Asia Project II.
Mejia N, Abimbola T, Andrews JR. Clin Infect Dis. 2020;71(Suppl 3):S306–S318. doi: 10.1093/cid/ciaa1335.

Typhoid and paratyphoid cost of illness in Bangladesh: Patient and health facility costs from the Surveillance for Enteric Fever in Asia Project II.
Mejia N, Pallas SW, Saha S, et al. Clin Infect Dis. 2020;71(Suppl 3):S293-S305. doi: 10.1093/cid/ciaa1334.

Typhoid and paratyphoid cost of illness in Pakistan: Patient and health facility costs from the Surveillance for Enteric Fever in Asia Project II.
Mejia N, Qamar F, Yousafzai MT, et al. Clin Infect Dis. 2020;71(Suppl 3):S319–S335. doi: 10.1093/cid/ciaa1336.

Methodological considerations for cost of illness studies of enteric fever.
Mejia N, Ramani E, Pallas SW, Song D, Abimbola T, Mogasale V. Clin Infect Dis. 2020;71(Suppl 2):S111-S119. doi: 10.1093/cid/ciaa481.

Antimicrobial resistance in typhoidal salmonella: Surveillance for Enteric Fever in Asia Project, 2016-2019.
Qamar FN, Yousafzai MT, Dehraj IF, et al. Clin Infect Dis. 2020;71(Suppl 3):S276-S284. doi: 10.1093/cid/ciaa1323.

Spatial heterogeneity of enteric fever in 2 diverse communities in Nepal.
Tamrakar D, Vaidya K, Yu AT, et al. Clin Infect Dis. 2020;71(Suppl 3):S205-S213. doi: 10.1093/cid/ciaa1319.

Antibiotic use prior to hospital presentation among individuals with suspected enteric fever in Nepal, Bangladesh, and Pakistan.
Vaidya K, Aiemoy K, Qamar FN, et al. Clin Infect Dis. 2020;71(Suppl 3):S285-S292. doi: 10.1093/cid/ciaa1333.

A cluster-based, spatial-sampling method for assessing household healthcare utilization patterns in resource-limited settings.
Yu AT, Shakya R, Adhikari B, et al. Clin Infect Dis. 2020;71(Suppl 3):S239-S247. doi: 10.1093/cid/ciaa1310.

Selection From Previous Years

Lessons learned from emergency response vaccination efforts for cholera, typhoid, yellow fever, and Ebola.
Walldorf JA, Date KA, Sreenivasan N, Harris B, Hyde TB. Emerg Infect Dis. 2017;23(13):S210-S216. doi: 10.3201/eid2313.170550.